Skip to content
DraconiticResearch
Search Sources API
201,818 studies31 sourcesUpdated 48 min ago
PreprintCC BY-NC-NDbioRxiv

An immune world model with multi-agent orchestration for peptide vaccines

  1. 1Shanghai Jiao Tong University

Abstract

Peptide-vaccine design requires a connection between vaccine-induced priming and recognition of the antigen naturally displayed by a tumor. We present an immune world model that preserves this connection through separate vaccine and tumor branches, endpoint-specific evidence and multi-agent orchestration. Native-recognition constraints held an altered peptide despite its higher presentation score, and targeted perturbations removed antigen-dependent benefit when required tumor-recognition conditions were absent. Public dendritic-cell data distinguished donor from antigen-source transfer: a context ranker achieved Recall@20 of 0.483 and 0.333 under the respective holdouts. Structure-informed receptor prediction added candidate-ranking evidence while preserving functional constraints and matched scenario trajectories. An assay observation model further concentrated a cross-presentation coefficient around its known value in a synthetic conditioning experiment. Together, these results establish a computational framework for linking molecular predictions, native-target requirements and conditional immune dynamics. The framework provides a reproducible basis for choosing peptide-vaccine candidates and the experiments needed to resolve their biological dependencies.

Related

  1. Accelerating Molecular Dynamics with Hydrogen Mass Repartitioning to Prioritize Immunogenic Neoantigens for Cancer Vaccines through Peptide HLA Binding Free Energy Calculations
    D. A. Amaya-Ramirez, J. B. Florez-Suarez, J. D. Mora-Fonseca +1
    bioRxivPreprintCC BYFull textImmunologybioRxiv
  2. Steering the immune response: cancer vaccines and the next era of cancer immunotherapy
    James L Gulley, Lisa H Butterfield
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textImmunologyDOAJ
  3. Atomic layer deposition for core-shell microparticle vaccines enabling programmable antigen delivery and enhanced humoral immune responses
    N. Chaudhary, H. J. Coleman, E. V. Paolone +18
    bioRxivPreprintCC BYFull textImmunologybioRxiv
  4. Personalized cancer vaccines: bridging immune-oncology and precision medicine for advanced therapeutics
    Leiguang Ye, Guo Zhao, Jiaxiu Ma +6
    Signal Transduction and Targeted TherapyPeer-reviewedCC BY-NC-NDFull text10 citedImmunologyOpenAlex
  5. Kupffer cells are key mediators of antigen-specific immune tolerance by peptide-coupled red blood cells
    Vasileia Kalaitzaki, Pietro Oldrati, Filipa M. Ferreira +13
    Science AdvancesPeer-reviewedLicence not statedImmunologyCrossref
BibTeX
@misc{chen2026immune,
  title = {{An immune world model with multi-agent orchestration for peptide vaccines}},
  author = {L. Chen and H. Luan and G. Yu},
  howpublished = {bioRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.19.760096},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.19.760096v1},
  note = {CC BY-NC-ND},
}
RIS
TY  - UNPB
TI  - An immune world model with multi-agent orchestration for peptide vaccines
AU  - L. Chen
AU  - H. Luan
AU  - G. Yu
PY  - 2026
DA  - 2026/10/19
PB  - bioRxiv
DO  - 10.64898/2026.10.19.760096
UR  - https://www.biorxiv.org/content/10.64898/2026.10.19.760096v1
AB  - Peptide-vaccine design requires a connection between vaccine-induced priming and recognition of the antigen naturally displayed by a tumor. We present an immune world model that preserves this connection through separate vaccine and tumor branches, endpoint-specific evidence and multi-agent orchestration. Native-recognition constraints held an altered peptide despite its higher presentation score, and targeted perturbations removed antigen-dependent benefit when required tumor-recognition conditions were absent. Public dendritic-cell data distinguished donor from antigen-source transfer: a context ranker achieved Recall@20 of 0.483 and 0.333 under the respective holdouts. Structure-informed receptor prediction added candidate-ranking evidence while preserving functional constraints and matched scenario trajectories. An assay observation model further concentrated a cross-presentation coefficient around its known value in a synthetic conditioning experiment. Together, these results establish a computational framework for linking molecular predictions, native-target requirements and conditional immune dynamics. The framework provides a reproducible basis for choosing peptide-vaccine candidates and the experiments needed to resolve their biological dependencies.
ER  -